The Global Bipolar Forceps Market is expected to grow at a CAGR during the forecasting period (2021-2028).
Bipolar forceps are revolutionary instruments that show similar characteristics to normal surgical forceps but offer different functionality. Bipolar forceps are connected to a bipolar cable that produced bipolar energy output provided by electrosurgical generators. Surgical forceps are used to open and hold tissues, while on the other side, bipolar forceps are meant to grasp, manipulate, and coagulate selected tissues. This involves changing the state of tissues into solid or semisolid by applying electric current between the device’s two tips, reducing the length of the current’s path, and producing a precise and controlled therapeutic effect. These devices are in great demand that requires critically precise temperature control and reduces tissue sticking and burning while the tissue coagulates.
Download free sample: https://www.datamintelligence.com/download-sample/bipolar-forceps-market
The global bipolar forceps market is majorly driven by the growing prevalence of chronic diseases that require microsurgeries and the increasing demand for minimally invasive surgeries. Growing technological advancements in bipolar forceps devices have created opportunities for the device to cover the broad spectrum of application base.
Increasing prevalence of chronic diseases requiring microsurgeries and growing demand for minimally invasive surgeries
As per World Population Ageing 2019, there were nearly 703 million people aged 65 or above 65 across the world in 2019, and the number is expected to get double by 1.5 million by the end of 2050. This growing geriatric population is adding values to the global population suffering from chronic disease; as per World Health Organisation 2018, chronic diseases kills nearly 41 million of the world’s population every year and out of which cardiovascular diseases accounts for around 17.9 million people, followed by cancer with around 9 million and respiratory diseases 3.9 million of the total population annually. These rising numbers of chronic diseases have created a huge demand for bipolar forceps devices and expect to maintain the forecast period’s momentum. According to the Global Nursing and Healthcare Conference, in 2016, nearly 234 million surgical procedures were performed worldwide. These rising surgeries have uplifted the demand for microsurgeries in some severe cancer trauma cases and raised the demand for bipolar forceps in microsurgical procedures.
In November 2016, HOYA Group PENTAX Medical came up with HemoStat WideCup to support the rising demand for endoscopic procedures. It is new bipolar hot hemostasis forceps to attain easy bleeding control during endoscopic therapy procedures.
Ambulatory Surgical Centres
View full report: https://www.datamintelligence.com/research-report/bipolar-forceps-market
North American region holds the largest market share global bipolar forceps market.
North America region holds the highest market for bipolar forceps market in present times and expected to maintain dominance in the coming years. According to the American Heart Association, over 92.1 million of the population lived with different cardiovascular diseases until 2017. This rising chronic disease rate in the region is expected to propel the market of bipolar forceps in the conjecture time frame. Also, around 51.4 million surgeries were performed solely in the U.S in 2014. The number increased to around 5-7% in the past few years, and this rising number is propelling the demand for bipolar forceps devices in the forecast period. The rising prevalence of minimally invasive surgeries, especially in outpatient settings, adds value to the market’s overall growth.
The bipolar forceps market is highly competitive, with the presence of various global companies. Some of the key players contributing to the market’s growth include B.Braun, Medtronic, Erbe, Codman, Pentax Medical, Ethicon, Geyi, Sutter, Faulhaber Pinzetten, and Johnson & Johnson, among others.
The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the global bipolar forceps market.
- In February 2019, Erbe brought its fourteen reusable models with 4 premium forceps and 6 classic forceps, which can be used for more surgical applications.
- In November 2016, HOYA Group PENTAX Medical came up with HemoStat WideCup, is new bipolar hot hemostasis forceps to attain easy bleeding control during endoscopic therapy procedures.
Sai Kiran Sales Manager at DataM Intelligence Email: [email protected] Tel: +1 877 441 4866 Website: www.datamintelligence.com